
Vietnam's Pharmaceutical Landscape
As a developing country, Vietnam has experienced robust economic growth in the past several years. With a population
of over 97 million people, the country has become an attractive market for various
industries, including medicine. With growing technological innovations, Vietnam is the ideal destination to develop the pharmaceutical industry.
Challenges in Vietnam
Currently, Vietnam’s technological advancement and innovation in pharmaceutical R&D
remain in the early stages of growth. Moreover, Vietnam’s population is relatively young, with a
median age lower than many developed nations, making it challenging to expand the
pharmaceutical industry with low prevalence of age-related and chronic diseases.
Read More
(Vietnam Briefing, 2022)
Opportunities in Vietnam
On the other hand, the Vietnamese pharmaceutical market has shown steady growth with a compound annual growth rate of approximately 10%. This is expected to continue as the population ages further in the future and the prevalence of chronic diseases increases. Additionally, In Vietnam, customers tend to prioritize affordable and accessible healthcare options. As a result, generic drugs have become increasingly popular, accounting for a significant portion of the pharmaceutical market.
Read More
(Vietnam Plus, 2025)
Read More About What's Happening in Vietnam's Pharmaceutical Market
Stay informed and up-to-date with the evolving policies of Vietnamese law.
"Vietnam eyes $10 billion Pharma market by 2026, ramps up investment attraction & production"
April 08, 2025
Overview
This article explores the emerging policies that the Vietnamese government has implemented for 2025. These laws aim to strengthen the Pharma market by 10 billion USD in 2026, with current value of 7 billion USD in 2025 (VnEconomy, 2025).
"Potential gains and concerns in nation’s Pharma landscape"
May 02, 2025
Overview
This article discusses the difficult laws that the Vietnamese government imposes for the Pharmaceutical industry and how these need to be altered not only to improve healthcare outcomes in Vietnam, but also contribute positively to the nation's GDP growth (Vietnam Investment Review, 2025).
"Vietnam’s Amended Pharmaceutical Law: Navigating the Key Changes"
February 11, 2025
Overview
This article gives insights into the future changes that the Vietnamese government is planning to implement in the Pharma industry. These new policies will take effect starting July 1, 2025, and will include modernizing the market via expansion of e-commerce sales, streamlining drug registration, etc (Vietnam Briefing, 2025).
Key-Metrics on Vietnam's Pharma Consumer Trends
Health Insurance Holders in 2024 Vietnam
94%
Pharma Import value 2024 (Billions USD)
$4.4+
Expected Urbanization Rate by 2025
45%
Annual Growth Rate For Pharmaceuticals
10%
Manufacturing Plants
250
Import-Export Facilities
200+
Total Wholesale Agents
4,300
Total Retail Agents
62,000+